Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis
Public ClinicalTrials.gov record NCT00750139. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of NAFT-500 in Subjects With Tinea Pedis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A research study to compare the safety and effectiveness of an investigational medication called NAFT-500 to placebo, when used in subjects with tinea pedis (athlete's foot).
Study identification
- NCT ID
- NCT00750139
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 707 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2008 (Type not available)
- Primary completion
- Aug 2009 (Actual)
- Completion
- Dec 2009 (Actual)
- Last update posted
- Apr 26, 2013
2008 – 2009
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research | Birmingham | Alabama | 35209 | — |
| Dr. Felix Sigal | Los Angeles | California | 90010-3209 | — |
| University of California San Francisco, Dept of Dermatology | San Francisco | California | 94115 | — |
| FXM Research | Miami | Florida | 33175 | — |
| FXM Research | Miramar | Florida | 33027 | — |
| Glazer Dermatology | Buffalo Grove | Illinois | 60089 | — |
| Tulane University Health Services | New Orleans | Louisiana | 70112 | — |
| Silverton Skin Institute | Grand Blanc | Michigan | 48439 | — |
| Zoe Draelos, MD | High Point | North Carolina | 27262 | — |
| Haber Dermatology | Euclid | Ohio | 44118 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Paddington Testing Company | Philadelphia | Pennsylvania | 19103 | — |
| Temple University School of Podiatric Medicine | Philadelphia | Pennsylvania | 19107 | — |
| Coastal Carolina Research Center | Mt. Pleasant | South Carolina | 29464 | — |
| J & S Studies | College Station | Texas | 77845 | — |
| Research Across America | Dallas | Texas | 75234 | — |
| Research Across America | Plano | Texas | 75093 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00750139, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2013 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00750139 live on ClinicalTrials.gov.